Ocugen, Inc. SEC filings OCGN
Ocugen, Inc. has 892 filings in SEC EDGAR's recent list, going back to Aug 7, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 4, 2026 | — |
| 424B5 | Prospectus supplement | Jan 21, 2026 | — |
| 424B5 | Prospectus supplement | Aug 11, 2025 | — |
| S-8 | Employee stock plan registration | Mar 5, 2025 | — |
| S-3 | Shelf registration | Jan 31, 2025 | — |
| 424B5 | Prospectus supplement | Aug 1, 2024 | — |
| 424B5 | Prospectus supplement | Jul 31, 2024 | — |
| S-3 | Shelf registration | Apr 18, 2024 | — |
| S-8 | Employee stock plan registration | Apr 18, 2024 | — |
| 424B5 | Prospectus supplement | May 25, 2023 | — |
| 424B5 | Prospectus supplement | May 23, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2023 | — |
| POS AM | Filing | Feb 28, 2023 | — |
| 424B5 | Prospectus supplement | Jun 10, 2022 | — |
| S-8 | Employee stock plan registration | Feb 28, 2022 | — |
| S-8 | Employee stock plan registration | Feb 28, 2022 | — |
| 424B5 | Prospectus supplement | Feb 24, 2022 | — |
| 424B5 | Prospectus supplement | Feb 22, 2022 | — |
| 424B7 | Filing | Aug 6, 2021 | — |
| 424B5 | Prospectus supplement | Apr 27, 2021 | — |
| S-3ASR | Automatic shelf registration | Mar 22, 2021 | — |
| S-8 | Employee stock plan registration | Mar 22, 2021 | — |
| 424B5 | Prospectus supplement | Feb 9, 2021 | — |
| 424B5 | Prospectus supplement | Aug 17, 2020 | — |
| 424B5 | Prospectus supplement | Jun 12, 2020 | — |
| 424B5 | Prospectus supplement | May 8, 2020 | — |
| S-3 | Shelf registration | Mar 27, 2020 | — |
| S-8 | Employee stock plan registration | Mar 27, 2020 | — |
| 424B3 | Prospectus | Nov 6, 2019 | — |
| S-3/A | Filing | Oct 28, 2019 | — |
| S-3 | Shelf registration | Oct 7, 2019 | — |
| 424B3 | Prospectus | Aug 6, 2019 | — |
| S-4/A | Filing | Aug 2, 2019 | — |
| S-4/A | S-4/a amendment #1 | Jul 23, 2019 | — |
| S-4 | Registration for a merger or exchange | Jun 14, 2019 | — |
| 424B3 | Prospectus | Feb 8, 2019 | — |
| 424B5 | Prospectus supplement | Oct 5, 2018 | — |
| 424B5 | Prospectus supplement | Oct 5, 2018 | — |
| S-3 | Shelf registration | Aug 17, 2018 | — |
| 424B5 | Prospectus supplement | Mar 15, 2018 | — |
| S-8 | Employee stock plan registration | Mar 15, 2018 | — |
| 424B5 | Prospectus supplement | Jan 24, 2018 | — |
| 424B3 | Prospectus | Jan 22, 2018 | — |
| S-8 | Employee stock plan registration | Mar 16, 2017 | — |
| S-3 | Shelf registration | Mar 16, 2017 | — |
| 424B3 | Prospectus | Nov 4, 2016 | — |
| S-3 | Shelf registration | Oct 5, 2016 | — |
| S-8 | Employee stock plan registration | Jun 30, 2016 | — |
| S-8 | Employee stock plan registration | Mar 10, 2016 | — |
| S-8 | Employee stock plan registration | Jan 16, 2015 | — |
| 424B4 | Prospectus | Dec 3, 2014 | — |
| S-1/A | Amended registration statement | Dec 2, 2014 | — |
| FWP | Free writing prospectus | Nov 26, 2014 | — |
| S-1/A | Amended registration statement | Nov 26, 2014 | — |
| S-1/A | Amended registration statement | Nov 14, 2014 | — |
| S-1/A | Amended registration statement | Nov 7, 2014 | — |
| S-1 | Registration statement | Oct 7, 2014 | — |
Showing 58 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- OCGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Malvern, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1372299
- Former names
- HISTOGENICS CORP (until Sep 26, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.